ENSOMA
Ensoma is expanding the reach of the curative power of genomic medicine by pioneering a next-generation in vivo approach using its Engenious™ vectors. Ensoma’s vectors are designed to deliver a diverse range of gene modification technologies without the need for stem cell collection or prior myeloablative conditioning (e.g., chemotherapy). As a result, Ensoma’s therapies can be delivered as a single injection in a diverse range of settings, including outpatient and settings where access to sophisticated healthcare systems may be limited.
ENSOMA
Industry:
Biotechnology Genetics Therapeutics
Founded:
2019-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.ensoma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
70 M USD
Technology used in webpage:
SSL By Default LetsEncrypt Content Delivery Network Mobile Non Scaleable Content Nginx Amazon Apple Mobile Web App Capable Amazon S3 CDN Apple Mobile Web App Status Bar Style Java EE
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Chroma Medicine
Chroma Medicine is a new genomic medicine company working on epigenetic editing.
Genome Technology Access Center
A full-service genomics service company
ImmuneID
ImmuneID is a precision immunology company.
CareDx
CareDx is a novel molÂeÂcÂuÂlar diagnosÂtics comÂpany.
Current Advisors List
Current Employees Featured
Founder
Investors List
Takeda Ventures
Takeda Ventures investment in Series A - Ensoma
Viking Global Investors
Viking Global Investors investment in Series A - Ensoma
5AM Ventures
5AM Ventures investment in Series A - Ensoma
RIT Capital Partners
RIT Capital Partners investment in Series A - Ensoma
SymBiosis LLC
SymBiosis LLC investment in Series A - Ensoma
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Ensoma
F-Prime Capital
F-Prime Capital investment in Series A - Ensoma
Cormorant Asset Management
Cormorant Asset Management investment in Series A - Ensoma
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-11 | Ensoma Taps Gene Therapy Leader as First CEO |
Official Site Inspections
http://www.ensoma.com
- Host name: 63.2.231.35.bc.googleusercontent.com
- IP address: 35.231.2.63
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
